QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

FTRE

QT72Fortrea Holdings Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
15.31
-0.01-0.07%
OverviewShort InterestFilings
FTREQT72Fortrea Holdings Inc.·NASDAQ
OverviewShort InterestFilings
15.31-0.07%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-4.93
Insider Own3.31%
Shs Outstand94.60M
Perf Week-9.25%
Market Cap1.45BForward P/E15.16EPS next Y1.01Insider Trans0.85%Shs Float-Perf Month11.67%
Enterprise Value2.42BPEG-EPS next Q0.18Inst Own-Short Float-Perf Quarter56.38%
Income-463547277.00P/S0.54EPS this Y116.17%Inst Trans-Short Ratio-Perf Half Y-4.25%
Sales2.71BP/B2.66EPS next Y26.69%ROA-16.65%Short Interest-Perf YTD-11.25%
Book/sh5.56P/C6.33EPS next 5Y28.37%ROE-79.12%52W High18.67 -18.00%Perf Year180.40%
Cash/sh1.56P/FCF7.61EPS past 3/5Y-ROIC-0.83%52W Low4.36 251.15%Perf 3Y-
Dividend Est.-EV/EBITDA-8.61Sales past 3/5Y-1.36% 1.08%Gross Margin15.97%Volatility3.27% 4.36%Perf 5Y-
Dividend TTM-EV/Sales0.89EPS Y/Y TTM115.26%Oper. Margin-0.54%ATR (14)0.96Perf 10Y-
Dividend Ex-Date-Quick Ratio0.95Sales Y/Y TTM0.48%Profit Margin-16.50%RSI (14)51.71Recom2.29
Dividend Gr. 3/5Y-Current Ratio0.95EPS Q/Q-SMA20-1.18%Beta2.84Target Price18.17
Payout0.00%Debt/Eq2.13Sales Q/Q-2.15%SMA5014.15%Rel Volume2.18Prev Close15.32
Employees15,000LT Debt/Eq1.95EarningsAug 05SMA20022.96%Avg Volume1.38MPrice15.31
IPO DateJun 20, 2023Option/ShortYes / YesEPS/Sales Surpr.433.33% 1.27%Net Debt/EBITDA-3.45Volume3,008,109Change-0.07%
Analyst Ratings
DateActionAnalystRatingTarget
May-07-26ReiteratedDeutsche BankHold$11 → $14
May-06-26ReiteratedTruist Financial$16 → $19
May-06-26ReiteratedRobert W. Baird$15 → $20
May-06-26ReiteratedBarclaysEqual Weight$11 → $16
Apr-14-26ReiteratedBarclaysEqual Weight$15 → $11
Mar-09-26UpgradeTD CowenHold → Buy
Jan-14-26ReiteratedRobert W. Baird$15 → $19
Jan-09-26ReiteratedMizuho Securities$13 → $15
Jan-08-26ReiteratedTruist Financial$22
Jan-08-26UpgradeTruist SecuritiesHold → Buy
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
Total Revenue2,7092,7232,696
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A2,2762,2982,162
Gross Profit433426534
Selling, General and Administrative Excl. Other436456561
Research and Development
000
Other Operating Expense120135
Operating Income-15-31-162
Interest Expense8891124
Unusual Expense
———
Non-Operating Income (Expense)345861-11
Net Income Before Taxes-448-983-275
Income Taxes-13-3
Consolidated Net Income-447-986-328
Net Income From Continuing Operations-447-986-271
Net Income-447-986-328
EPS (Recurring)-4.93-10.81-3.67
EPS (Basic, Before Extraordinaries)-4.93-10.81-3.67
EPS (Diluted)-4.93-10.81-3.67
EBITDA-281-814-64
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio0.510.58—
Gross Margin15.9815.6419.81
Operating Margin-0.55-1.14-6.01
Net Margin-16.50-36.21-12.17
Shares Outstanding919190
Market Capitalization1,3931,570—
Operating Lease Expense
———
Insider Trading Volume
$16.81$15.92$15.04$14.16$13.27● Close Price0.00K101.79K203.57K305.36K407.15KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
SANDERS MACHELLEDirectorJun 10 '26Option Exercise0.0077,634046,099Jun 12 12:00 AM
Ray AmritDirectorJun 10 '26Option Exercise0.0077,634052,453Jun 12 12:00 AM
Russell Erin LDirectorJun 10 '26Option Exercise0.0077,634072,617Jun 12 12:00 AM
Smith David RossDirectorJun 10 '26Option Exercise0.0077,634048,361Jun 12 12:00 AM
Pesicka Edward ADirectorJun 10 '26Option Exercise0.0077,634052,453Jun 12 12:00 AM
Morais Mark A.Chief Operating OfficerJun 10 '26Sale16.824,67478,61771,365Jun 12 12:00 AM
Parks RobertChief Accounting OfficerMay 18 '26Sale13.442,00026,88020,389May 20 12:00 AM
NEUPERT PETER MDirectorMay 14 '26Option Exercise0.00297,0720246,668May 18 12:00 AM
Russell Erin LDirectorMar 20 '26Option Exercise0.0047,892038,817Mar 24 12:00 AM
Morais Mark A.Chief Operating OfficerMar 16 '26Sale9.221,80416,63369,899Mar 17 12:00 AM
Mcconnell Jill G.Chief Financial OfficerMar 16 '26Sale9.221,80416,63372,276Mar 17 12:00 AM
Morais Mark A.Chief Operating OfficerMar 13 '26Option Exercise0.008,5680113,001Mar 17 12:00 AM
Mcconnell Jill G.Chief Financial OfficerMar 13 '26Option Exercise0.008,5680151,847Mar 17 12:00 AM
Morais Mark A.Chief Operating OfficerMar 10 '26Sale9.074,59941,71367,419Mar 11 12:00 AM
Parks RobertChief Accounting OfficerMar 10 '26Sale9.071,92717,47822,389Mar 11 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR